
Postdoc researcher at EMBL-EBI @emblebi interested in cancer genomics and liquid biopsies 🧬👩🏻💻 Ballet and rowing enthusiast
Cambridge, England
Joined November 2019
- Tweets129
- Following401
- Followers311
- Likes504
Pinned Tweet
Thrilled to share our latest work now out in @naturemethods 🥳 We present SAVANA, a novel machine-learning based algorithm to detect somatic structural variants and copy number aberrations from long-read (@nanopore & @PacBio ) sequencing data with and without matched control!👇
Introducing SAVANA, a tool to detect somatic structural variants and copy number aberrations from long-read sequencing data with high sensitivity and specificity.
nature.com/articles/s41592-0…
Carolin Sauer retweeted
The last call of our VIDA Postdoctoral COFUND Programme is officially OPEN‼️ 🚀
Funded by a Marie Skłodowska-Curie Actions COFUND Grant, #VHIOVIDAEU is recruiting 4️⃣ postdocs.
🗓️ Apply by Aug 20 👉 linke.to/VHIOVIDAprogramme25
#VHIOVIDA #TranslationalResearch #VHIOAcademy
Carolin Sauer retweeted
ONT long-read sequencing based analysis of cell-free DNA in pediatric cancer patients. Highly amplified regions through ecDNA provided signal for disease progression prior to radiographic/clinical evidence. Congratulations on the huge work @isidrolauscher and @Carolinmsa !!
We are thrilled to present **SIMMA**, a liquid biopsy assay for low-input single-molecule sequencing of cfDNA with multimodal data integration. See below to learn about its large-scale clinical validation across diverse tumour types, ecDNA detection etc👇
medrxiv.org/content/10.64898…
Carolin Sauer retweeted
We are thrilled to present **SIMMA**, a liquid biopsy assay for low-input single-molecule sequencing of cfDNA with multimodal data integration. See below to learn about its large-scale clinical validation across diverse tumour types, ecDNA detection etc👇
medrxiv.org/content/10.64898…
Very excited to share our new preprint out on medRxiv 🎉 medrxiv.org/content/10.64898…
We present SIMMA, a multimodal low-input cfDNA single-molecule sequencing approach, allowing the detection of ctDNA down to ~100ppm and excitingly also the detection of ecDNA from liquid biopsies! 👇
6) This has been a huge team effort! Big thank you to @isidrolauscher for all his support over the last years and the entire group! I am also incredibly grateful to all collaborators, especially Andrew Beggs' team, and the entire SMPaeds consortium! Thank you all very much! 🙏
Carolin Sauer retweeted
An incredible piece of work from our group! ✨️🧬👩🏻💻
This work demonstrates a technical advance based on liquid biopsies exploration, with very interesting insights, particularly in pediatric cancer.
We're so proud of you @Carolinmsa !! 👏🏼👏🏼👏🏼
medrxiv.org/content/10.64898…
Carolin Sauer retweeted
Postdoc Opening at EPFL - please share!
I am hiring a post-doctoral fellow here in the Laboratory for Energy Materials at EPFL to work on the next generation of quantum light sources, with an earliest start date of January 2026 for up to 4 years.
#quantum #light #energymaterials
Great to see this out! Huge congrats to everyone involved!
🚨Chemo treatment upgrade!🚨
Check out our approach to modernise chemotherapy treatment published today in @NatureGenet. From @CNIOStopCancer @TailorBio @CR_UK nature.com/articles/s41588-0… More details 👇
This work paves the way for more reliable application of long-read sequencing in detecting SVs and SCNAs in cancer genomics!
Huge thank you particularly to @hbelrick & @isidrolauscher and all co-authors and collaborators involved in this work! And also thank you to @emblebi for a great article showcasing and summarising SAVANA: lnkd.in/eXZ_p9XY
Carolin Sauer retweeted
Thrilled to see #SAVANA out in @naturemethods🥳 SAVANA detects haplotype-resolved somatic SVs and copy number aberrations (SCNAs) and infers tumour purity & ploidy in clinical samples using long-read sequencing with or WITHOUT a matched germline control 👇nature.com/articles/s41592-0…
Join me at the International Symposium on Minimal Residual Cancer, where I am honoured to be speaking in Nice this May along leading experts from around the world to discuss the latest breakthroughs in liquid biopsy, circulating biomarkers, and precision oncology.✨ #ISMRC2025
Carolin Sauer retweeted
#ResearchWatch: aacrjournals.org/cdnews/news…
Loss–Translocation–Amplification #Chromothripsis Drives #Osteosarcoma Evolution, a summary of the study by @je_valleinclan, Solange De Noon, Adrienne Flanagan, @isidrolauscher, @emblebi @sangerinstitute @GenomicsEngland @uclcancer













